Description
BSE lists 1500 commercial papers of Nuvama Wealth Management Limited worth Rs. 5 lakhs each, issued on private placement basis with maturity on March 2, 2026.
Summary
BSE has listed new commercial papers issued by Nuvama Wealth Management Limited on private placement basis. The listing comprises 1500 securities with face value of Rs. 5,00,000 each, totaling Rs. 75 crores. The commercial papers are issued at a discount (Rs. 491,061.50) and will mature on March 2, 2026. ICICI Bank Ltd acts as the Issuing and Paying agent.
Key Points
- Securities: Commercial Paper issued on private placement basis
- Quantity: 1500 units
- Face Value: Rs. 5,00,000 per unit
- Issue Price: Rs. 4,91,061.50 (issued at discount)
- Scrip Code: 730697
- Scrip ID: NWML31225
- Detail Name: NWML-2-3-26-CP
- ISIN: INE531F14FL4 (further listing under same ISIN)
- Credit Rating: CARE A1+, CRISIL A1+
- Market Lot: 1 unit
- Standard Denomination: Rs. 5 lakhs and multiples thereof
- Tick Size: 1 paise
- Allotment Date: December 4, 2025
- Redemption Date: March 2, 2026
- Issuing and Paying Agent: ICICI Bank Ltd
Regulatory Changes
No regulatory changes announced. This is a routine listing notification.
Compliance Requirements
- Trading members must note that securities will be traded only in dematerialized form under ISIN INE531F14FL4
- Trading shall take place in standard denomination of Rs. 5 lakhs and multiples thereof
- Trading members requiring clarification may contact BSE debt department on 22728352/8597/8995/5753/8915
Important Dates
- Listing Date: December 5, 2025
- Allotment Date: December 4, 2025
- Redemption Date: March 2, 2026
- Tenure: Approximately 88 days (short-term instrument)
Impact Assessment
Market Impact: Low - This is a routine commercial paper listing in the debt segment with no impact on equity markets or broader market operations.
Investor Impact: Minimal - Relevant only to debt market participants and institutional investors interested in short-term, highly-rated commercial paper instruments.
Operational Impact: None - Standard listing procedure with established trading parameters. The high credit ratings (CARE A1+ and CRISIL A1+) indicate top-tier creditworthiness for short-term debt instruments.
Impact Justification
Routine commercial paper listing with no market-wide impact, affects only debt segment trading members and investors interested in short-term debt instruments